Asthma is a manifestation of bronchial hyperreactivity (BHR) and forms part of the spectrum of atopic disease. Some Background. Bronchial hyperresponsiveness, a risk factor for asthma, consists of a heightened bronchoconstrictor response to a variety of stimuli. The condition has a heritable component and is closely related to serum IgE levels and airway inflammation. The basis for these relations is unknown, as is the mechanism of genetic susceptibility to bronchial hyperresponsiveness. We attempted to define the interrelation between atopy and bronchial hyperresponsiveness and to investigate the chromosomal location of this component of asthma. Methods. We studied 303 children and grandchildren of 84 probands with asthma selected from a homogeneous population in the Netherlands. Ventilatory function, bronchial responsiveness to histamine, and serum total IgE were measured. The association
total IgE is coinherited with a trait for bronchial hyperresponsiveness and that a gene governing bronchial hyperresponsiveness is located near a major locus that regulates serum IgE levels on chromosome 5q. These findings are consistent with the existence of one or more genes on chromosome 5q31-q33 causing susceptibility to asthma. (N Engl J Med 1 995;333:894-900)
Markers and linkage Perhaps the central issue in the aetiology of asthma is the relationship between bronchial hyperreactivity (BHR) measured by methacholine or histamine challenge, atopy defined as the propensity to make an exuberant IgE antibody response to antigen, and T cell cytokines. Family studies of BHR point to a strong genetic influence in man, with one or more genes controlling the response.' Unfortunately, human studies
give an imperfect approach to such questions because the breeding choices of the participants are not open to experiment. Mice, on the other hand, can be bred for differences in response to methacholine or their propensity to make IgE antibodies. Researchers can knock out individual murine genes to assess their contribution to a disease phenotype. In contrast, human aetiological studies require a very large number of subjects to be studied to control for the variables introduced by the genetic heterogeneity of an individual.
The identification of genes responsible for human disease has been fastest for disorders with a readily identifiable phenotype determined by only a single genetic locus -the rapid progress made in identifying the genes and aetiology of X-linked immunodeficiencies is a case in point.2 On the other hand, when genes on different chromosomes act together to produce a disorder, large numbers of subjects have to be studied to identify links between the inherited DNA (genotype) and the disorder (phenotype).
Linkage studies3 have become possible only in the past decade as microsatellite markers have been mapped to individual chromosomes. Microsatellites are short tandem repeats of two or more nucleotides that vary between individuals. Only small amounts of blood are required and the polymerase chain reactions used to identify microsatellites can be semi-automated. 4 The human genetic map based entirely on microsatellites has just been updated' and now comprises 5264 repeat polymorphisms distributed in 2335 positions with a total length of 3699 cM and mean interval of 1 6 cM. A centimorgan (cM) refers to one genetic map unit which is the distance between gene pairs for which one product of meiosis out of 100 is recombinant -that is, a recombinant frequency of 1%. The density of this map should make it easier to localise candidate genes linked to markers.
Linkage studies of complex multigene disorders, such as type 1 diabetes, first proved of value when they were "focused" on a specific group of genes such as the major histocompatibility complex (MHC) locus.6 However, the MHC gene is not the only one which contributes susceptibility to diabetes and a genome-wide search found that there were linked loci on chromosomes 6, 11, and 2 (the loci on 6 and 11 are close to the major histocompatibility complex and the insulin gene7). This knowledge is a stimulus to new approaches to prevention (for diabetes) and the analysis of genes contributing to asthma will be most valuable if it points to new aetiologies and new approaches to treatment.
The introductory articles by van Herwerden et al8 and Postma et al9 illustrate the "focused" approach to linkage studies in which siblings, parents, and children who share asthma are tested for shared DNA markers around specific chromosomal sites of interest. Sharing in excess of what would be predicted to occur by chance then implicates one or more genes close to the marker in the pathogenesis of the asthma. At first sight the reports appear contradictory with their fingers pointing to chromosome 11 and chromosome 5, respectively. Studies in mice point to one resolution for this dilemma and may help to guide further human studies.
Genetic control of bronchial hyperreactivity in mice Inbred strains of mice differ in their bronchial reactivity to methacholine.'°Crosses between high and low responder strains yielded distinct high and low responders" with an inheritance pattern which suggested that BHR could be inherited as an autosomal recessive trait. Markers for all mouse chromosomes have subsequently become available and De Sanctis and colleagues'2 have now used these to localise genes contributing to BHR in mice. fig 1) shows how the LOD score, the geneticist's measurement of linkage, rises to a peak as markers up and down the chromosome are examined. They found that about 50% of the variability in murine response to methacholine was genetically determined with the remaining 50% assumed to reflect environmental factors. When A/J mice (which have the highest response) and C57BL/6J (the lowest methacholine responders) were mated, the BHR of the offspring was normally distributed with a wide standard deviation, a result suggestive of a polygenic trait. The BHR of individual mice was determined by the origin of their chromosomes 2, 15, and 17, with the candidate genes on these being named BHR1, BHR2, and BHR3. The genes tended to interact in pairs, BHR1 with BHR3, and BHR2 with BHR3. These interactions make it difficult to estimate the contribution of individual loci to BHR but, taken together, the three loci account for about 26% of the genetic variance in BHR.
C57BL/6 mice sensitised to egg protein (ovalbumin) by injection and then challenged with an aerosol of the same protein make IgE antibodies and acquire BHR with increased numbers of circulating and bronchial lavage fluid eosinophils. ' to the inheritance of a marker in the D5S436 region of 5q31-q33 (fig 2) . The subjects with BHR tended to be concordant with respect to their serum IgE levels with the correlation increasing as BHR was more stringently defined. The serum IgE levels did not correlate with the degree of histamine sensitivity in the BHR tests. people may develop asthma which may continue even after the exposure is terminated. 25 Expectations for a quick and dramatic transition from "bench to bedside" of genetic research have met with a number of obstacles. The fact that the well designed studies of van Herwerden et al and Postma et al9 reach different conclusions regarding the genetic linkage of asthma underscores the complexity of the disease that clinicians struggle with in their daily practice. Nevertheless, the recent identification of major loci associated with diabetes,26 breast cancer,27 and essential hypertension confirms the usefulness of these methods for investigating the pathogenesis of complex genetic disorders. Thus, genetic studies of asthma and allergic diseases may help to identify the underlying immunopathological mechanisms. These studies could eventually lead to diagnosis prior to onset of clinical disease and help in the development of prevention strategies. If a genetic cause for asthma can be identified, then gene transfer therapy might be a feasible treatment option in the future.
